Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Sterile Compounding • 2025 Sterile Compounding Update (2.00 CPE)



Speakers
Holli Temple, Pharm.D.
Clinical Associate Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Learning Objectives 
  • Describe the role of proper aseptic technique in sterile compounding
  • Differentiate between commonly used references (e.g., package insert vs. ASHP’s Injectable Drug Information) and identify when each is most appropriate to use
  • Demonstrate basic aseptic technique during the hands-on practice session
 
This activity may be counted as two hours of CPE for sterile compounding maintenance 

Instructions
This program consists of one video and downloadable resources in PDF format.
 
To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date. 
 
Speaker information and disclosures can be found in the tabs below.   

 

Fee

$35.00

CE Hours

2.00

CE Units

0.200

Activity Type

  • Knowledge

Support/Credits

Continuing Education Credit
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Each of the following online activities is approved for 0.20 CEUs (2.00 contact hour) of continuing education credit. To receive 2.00 contact hour of CE credit for each course, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days). Participants must watch both videos and complete both evaluations to receive a total of 0.20 CEUs (2.00 contact hours). 
 

 

 

Sterile Compounding • 2025
 

Sterile Compounding 2025
 
Learning Objectives 
  • Describe the role of proper aseptic technique in sterile compounding
  • Differentiate between commonly used references (e.g., package insert vs. ASHP’s Injectable Drug Information) and identify when each is most appropriate to use
  • Demonstrate basic aseptic technique during the hands-on practice session
 
This activity may be counted as two hours of CPE for sterile compounding maintenance 

About the Speaker
Holli Temple, Pharm.D.
Clinical Associate Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
 
Holli Temple earned a BS in Biomedical Science from Texas A&M University, a BS in Pharmacy and a Pharm.D. from UT Austin College of Pharmacy. Holli practiced hospital pharmacy for 16 years, served on faculty at UT Austin College of Pharmacy for 12 years, and has taught the sterile compounding course and lab for 8 years. Teaching IV lab is like running a pharmacy for a semester! In a span of 9-10 labs, students develop the technical skills to aseptically compound preparations, apply knowledge of state and federal sterile compounding regulations to specific scenarios, and use drug information resources to determine how to accurately make a preparation. Holli also teaches in the Foundations of Patient-Centered Care course and coordinates the Care and Respect for Elders Program. Additionally, Dr. Temple facilitates an interprofessional team in Foundations for Interprofessional Collaborative Practice and serves as Project Faculty for third-year pharmacy students working with community mentors to create and deliver a Population Health Project. In her free time, Holli enjoys spending time with family and friends, running, hiking, and snow-skiing
Disclosure: Dr. Temple has no relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 


 

Activity Number

0067-0000-25-093-H07-P/T

Release Date: Dec 15, 2025
Credit Expiration Date: Sep 18, 2028

CE Hours

2.00